AZ to issue primary analysis for COVID-19 vaccine following ‘outdated information’ concerns
US data and safety monitoring board expressed ‘concern’ over initial trial data
Read More
Tag: NIAID
Synairgen’s inhaled COVID-19 treatment included in US trial
Trial is sponsored by the US National Institute of Allergy and Infectious Diseases (NIAID)
Read More
Regeneron kicks off Phase III trial of COVID-19 antibody cocktail
This follows a positive review from the Independent Data Monitoring Committee of REGN-COV2 Phase I safety results
Read More
Gilead’s remdesivir speeds COVID-19 recovery in US trial
Hospitalised patients with advanced COVID-19 who received remdesivir recovered faster than those given placebo
Read More
Lilly to test Olumiant, LY3127804 against COVID-19
The RA drug Olumiant will be assessed in patients hospitalised with the virus
Read More
Gilead to kickstart remdesivir coronavirus trial
The hopeful drug in question is Gilead’s investigational broad-spectrum antiviral treatment that was previously tested in humans with Ebola virus.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
